NCAN and metabolic dysfunction-associated steatotic liver disease: In our current study, we observed that higher plasma NCAN levels were causally associated with a reduced risk of MASLD, with the effect being driven by a cis-acting variant near NCAN. These findings highlight NCAN as a potentially important factor in the pathogenesis of MASLD.